SIGLEC14 and Alzheimer disease: We propose that the effect size and significance of association are masked through copy number variation not accounted for using the proxy SNP alone, i.e., loss of SIGLEC14 function likely increases risk, but the proxy SNP rs1106476 occasionally also marks the individuals with an extra SIGLEC14 copy, thus reducing the power of rs1106476 association with AD.